Vitiligo can be treated using various new and experimental therapies, such as narrow-band ultraviolet B microphototherapy (NB-UVB), narrow-band ultraviolet B excimer laser and monochromatic excimer light. The first is recommended for generalized vitiligo, whereas the latter two are indicated in patients affected by segmental and bilateral symmetrical vitiligo with < 20% cutaneous involvement. Medical treatments include topical corticosteroids and other topical treatments, such as antioxidants, tacrolimus and pimecrolimus, prostaglandin E, and vitamin D derivatives. Excellent therapeutic results can be achieved through combination treatments; surgical intervention is reserved for adolescent or adult patients with stable vitiligo.